Publication:
Is running associated with a lower risk of all-cause, cardiovascular and cancer mortality, and is the more the better? A systematic review and meta-analysis

dc.contributor.authorZeljko Pedisicen_US
dc.contributor.authorNipun Shresthaen_US
dc.contributor.authorStephanie Kovalchiken_US
dc.contributor.authorEmmanuel Stamatakisen_US
dc.contributor.authorNucharapon Liangruenromen_US
dc.contributor.authorJozo Grgicen_US
dc.contributor.authorSylvia Titzeen_US
dc.contributor.authorStuart J.H. Biddleen_US
dc.contributor.authorAdrian E. Baumanen_US
dc.contributor.authorPekka Ojaen_US
dc.contributor.otherVictoria University Melbourne, Institute for Health and Sporten_US
dc.contributor.otherThe University of Sydneyen_US
dc.contributor.otherKarl-Franzens-Universitat Grazen_US
dc.contributor.otherUniversity of Southern Queenslanden_US
dc.contributor.otherUKK Institute Finlanden_US
dc.contributor.otherMahidol Universityen_US
dc.date.accessioned2020-01-27T08:50:58Z
dc.date.available2020-01-27T08:50:58Z
dc.date.issued2019-01-01en_US
dc.description.abstract© Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ. Objective: To investigate the association of running participation and the dose of running with the risk of all-cause, cardiovascular and cancer mortality. Design: Systematic review and meta-analysis. Data sources: Journal articles, conference papers and doctoral theses indexed in Academic Search Ultimate, CINAHL, Health Source: Nursing/Academic Edition, MasterFILE Complete, Networked Digital Library of Theses and Dissertations, Open Access Theses and Dissertations, PsycINFO, PubMed/MEDLINE, Scopus, SPORTDiscus and Web of Science. Eligibility criteria for selecting studies: Prospective cohort studies on the association between running or jogging participation and the risk of all-cause, cardiovascular and/or cancer mortality in a non-clinical population of adults were included. Results: Fourteen studies from six prospective cohorts with a pooled sample of 232 149 participants were included. In total, 25 951 deaths were recorded during 5.5-35 year follow-ups. Our meta-analysis showed that running participation is associated with 27%, 30% and 23% lower risk of all-cause (pooled adjusted hazard ratio (HR)=0.73; 95% confidence interval (CI) 0.68 to 0.79), cardiovascular (HR=0.70; 95% CI 0.49 to 0.98) and cancer (HR=0.77; 95% CI 0.68 to 0.87) mortality, respectively, compared with no running. A meta-regression analysis showed no significant dose-response trends for weekly frequency, weekly duration, pace and the total volume of running. Conclusion: Increased rates of participation in running, regardless of its dose, would probably lead to substantial improvements in population health and longevity. Any amount of running, even just once a week, is better than no running, but higher doses of running may not necessarily be associated with greater mortality benefits.en_US
dc.identifier.citationBritish Journal of Sports Medicine. (2019)en_US
dc.identifier.doi10.1136/bjsports-2018-100493en_US
dc.identifier.issn14730480en_US
dc.identifier.issn03063674en_US
dc.identifier.other2-s2.0-85074801311en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/20.500.14594/50974
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85074801311&origin=inwarden_US
dc.subjectHealth Professionsen_US
dc.titleIs running associated with a lower risk of all-cause, cardiovascular and cancer mortality, and is the more the better? A systematic review and meta-analysisen_US
dc.typeReviewen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85074801311&origin=inwarden_US

Files

Collections